Literature DB >> 33033143

Rising Prostate Cancer Incidence in Sub-Saharan Africa: A Trend Analysis of Data from the African Cancer Registry Network.

Tobias P Seraphin1, Walburga Y Joko-Fru2,3, Bakarou Kamaté4, Eric Chokunonga5, Henry Wabinga6, Nontuthuzelo I M Somdyala7, Shyam S Manraj8, Olufemi J Ogunbiyi9, Charles P Dzamalala10,11, Anne Finesse12, Anne Korir13, Guy N'Da14, Cesaltina Lorenzoni15,16, Biying Liu2, Eva J Kantelhardt17,18, Donald M Parkin3,19.   

Abstract

BACKGROUND: Prostate cancer is the leading cancer in men in sub-Saharan Africa (SSA) regarding incidence and mortality. Published data from a few registries in SSA suggest that the rates are still rising, but there is little comprehensive information on the time trends of prostate cancer incidence.
METHODS: We analyzed registry data on 13,170 incident prostate cancer cases in men aged 40 years or above, from 12 population-based cancer registries in 11 SSA countries, with at least a 10-year time span of comparable data.
RESULTS: We observed an increase in cumulative risks (CR) and age-standardized incidence rates (ASR) over time in all registries (statistically significant in all but one). The highest values of CR were found in Seychelles and Harare (Zimbabwe). The highest annual increase in the ASRs was seen in Seychelles and Eastern Cape (South Africa), whereas the lowest was seen in Mauritius. We mainly found a steady increase in incidence with age and during successive periods.
CONCLUSIONS: This analysis reveals that prostate cancer incidence rates are rising in many populations in SSA-often very rapidly-which is in contrast to recent observations worldwide. We acknowledge that the reasons are multifactorial and largely remain unclear, but believe that they are primarily associated with improvements in health care systems, for example, a broader use of prostate-specific antigen testing. IMPACT: This study is the first to compare population-level data on time trends of prostate cancer incidence between multiple countries of SSA, presenting the different rates of increase in 11 of them. ©2020 American Association for Cancer Research.

Entities:  

Year:  2020        PMID: 33033143     DOI: 10.1158/1055-9965.EPI-20-1005

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  5 in total

1.  Prostate Cancer Patterns and Trends in the Eastern Cape Province of South Africa; 1998-2017.

Authors:  Thendo Michael Ramaliba; Nomfuneko Sithole; Akhona Ncinitwa; Nontuthuzelo I M Somdyala
Journal:  Front Public Health       Date:  2022-04-28

Review 2.  Supportive care needs of men with prostate cancer: A systematic review update.

Authors:  Jai Prashar; Patricia Schartau; Elizabeth Murray
Journal:  Eur J Cancer Care (Engl)       Date:  2022-01-17       Impact factor: 2.328

Review 3.  Ambient air pollution and non-communicable respiratory illness in sub-Saharan Africa: a systematic review of the literature.

Authors:  Bailey E Glenn; Peter S Larson; Leon M Espira; Miles C Larson
Journal:  Environ Health       Date:  2022-04-14       Impact factor: 5.984

4.  Efficacy and safety of Androgen Deprivation Therapy (ADT) combined with modified docetaxel chemotherapy versus ADT combined with standard docetaxel chemotherapy in patients with metastatic castration-resistant prostate cancer: study protocol for a multicentre prospective randomized controlled trial.

Authors:  Xiangwei Yang; Hong Chen; Duanya Xu; Xianju Chen; Yamei Li; Jun Tian; Dongwen Wang; Jun Pang
Journal:  BMC Cancer       Date:  2022-02-16       Impact factor: 4.430

5.  Prostate cancer survival in sub-Saharan Africa by age, stage at diagnosis, and human development index: a population-based registry study.

Authors:  Tobias P Seraphin; Walburga Y Joko-Fru; Shyam S Manraj; Eric Chokunonga; Nontuthuzelo I M Somdyala; Anne Korir; Guy N'Da; Anne Finesse; Henry Wabinga; Mathewos Assefa; Freddy Gnangnon; Rolf Hansen; Nathan G Buziba; Biying Liu; Eva J Kantelhardt; Donald M Parkin
Journal:  Cancer Causes Control       Date:  2021-07-10       Impact factor: 2.506

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.